文献速递泌尿男性生殖肿瘤

核孔外核孔蛋白sPOM121通过转录驱动β-连环蛋白介导的前列腺癌进展与免疫逃逸

Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer.
PubMed 文献 · Cancer Discov · 2025-01-01

本研究揭示核孔外核孔蛋白sPOM121在前列腺癌中高表达于核质,通过C端与染色质重塑因子SMARCA5在基因启动子区相互作用并定位于核凝聚体,重编程基因表达,调控包括β-连环蛋白在内的致癌基因网络,促进前列腺癌进展和免疫逃逸;靶向sPOM121/β-连环蛋白轴在患者来源临床前模型和同基因小鼠模型中可抑制侵袭性并增强抗肿瘤免疫。

要点

  • sPOM121是前列腺癌中主要表达的核质核孔蛋白。
  • sPOM121通过C端与SMARCA5在启动子区互作并定位于核凝聚体。
  • 靶向sPOM121/β-连环蛋白轴可抑制前列腺癌侵袭并增强免疫。

核心结论

  • 核孔外核孔蛋白sPOM121在前列腺癌中作为关键转录调节因子增强转移性前列腺癌的侵袭性。
  • sPOM121调控包括β-连环蛋白在内的致癌基因网络,促进前列腺癌进展和免疫逃逸。
  • 靶向sPOM121/β-连环蛋白轴在患者来源临床前模型和同基因小鼠模型中可阻止前列腺癌侵袭性并增强抗肿瘤免疫。

研究设计与样本

  • 研究采用人类样本的正交方法鉴定sPOM121为前列腺癌中主要表达的核质核孔蛋白。
  • 通过无偏蛋白质组学和表观基因组学研究分析sPOM121与SMARCA5的相互作用及基因表达重编程。
  • 在患者来源临床前模型和同基因小鼠模型中靶向sPOM121/β-连环蛋白轴评估疗效。

主要发现

  • sPOM121通过其C端与染色质重塑因子SMARCA5在基因启动子位点相互作用并定位于核凝聚体。
  • sPOM121调控一个独特的致癌基因网络,包括β-连环蛋白。
  • 靶向sPOM121/β-连环蛋白轴在患者来源临床前模型和同基因小鼠模型中阻止前列腺癌侵袭性并增强抗肿瘤免疫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The roles of nucleoplasm-residing nucleoporins (NUP) in solid tumors, including prostate cancer, remain unknown. In this study, we reveal the clinical significance and mechanistic role of the off-pore NUP, soluble POM121 (sPOM121), as a crucial transcriptional regulator that enhances the aggressiveness of metastatic prostate cancer. Using orthogonal methodologies in human samples, sPOM121 was identified as the predominantly expressed nucleoplasmic NUP in prostate cancer. Unbiased proteomic and epigenomic studies demonstrate that sPOM121, through its C-terminus, interacts with the chromatin remodeler SMARCA5 at gene promoter sites and localizes at nuclear condensates, reprogramming gene expression. Indeed, sPOM121 regulates a distinct oncogenic gene network, including β-catenin, leading to prostate cancer progression and immune evasion. Importantly, targeting the sPOM121/β-catenin axis in patient-derived preclinical and syngeneic mouse models halts prostate cancer aggressiveness and enhances antitumor immunity. Taken together, these findings reveal previously unknown actionable reprogramming functions of off-pore NUPs in solid tumors. SIGNIFICANCE: This study uncovers how oncogenic signaling programs are transcriptionally heightened by the NUP sPOM121 in metastatic prostate cancer. Localization of sPOM121 at active transcriptional nuclear condensates propels disease progression and immune evasion, offering novel anticancer therapeutic opportunities.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Kirthika P, Jawalagatti V, Li P, et al. Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer. Cancer Discov. 2025. PMID: 40709833. doi:10.1158/2159-8290.CD-25-0629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。